Q2 2018 La Jolla Pharmaceutical Co Earnings Call

8/8/2018 16:30

Conference Call La Jolla Pharmaceutical Co

La Jolla Pharmaceutical Co Conference call or earnings call will be held on Aug 8, 2018
During the earnings conference call’s session, La Jolla Pharmaceutical Co will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact La Jolla Pharmaceutical Co for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. We have several product candidates in development. LJPC-501 is our proprietary formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension. LJPC-401 is our novel formulation of synthetic human hepcidin for the potential treatment of conditions characterized by iron overload, such as hereditary hemochromatosis, beta thalassemia, sickle cell disease and myelodysplastic syndrome. LJPC-30S is our next-generation gentamicin derivative program that is focused on therapeutics for the potential treatment of serious bacterial infections as well as rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy. LJPC-501 LJPC-501 is our proprietary formulation of angiotensin II.
Read more Conference Call

La Jolla Pharmaceutical Co (LJPC)

4550 Towne Centre Court, San Diego California 92121, United States